(Q35141623)

6 August 2017

title

Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction (English)

1 reference

6 August 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24709669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Lina Badimon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24709669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1

Judit Cubedo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24709669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

20 March 2014

1 reference

6 August 2017

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24709669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24709669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24709669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

209-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24709669%20AND%20SRC:MED&resulttype=core&format=json

LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

High density lipoprotein cholesterol and mortality. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Identification and Quantification of Protein Glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Identification of de novo synthesized and relatively older proteins: accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

The HDL proteome in acute coronary syndromes shifts to an inflammatory profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Differential proteomic distribution of TTR (pre-albumin) forms in serum and HDL of patients with high cardiovascular risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Third universal definition of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Coordinated proteomic signature changes in immune response and complement proteins in acute myocardial infarction: the implication of serum amyloid P-component

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Retinol-binding protein 4 levels and susceptibility to ischaemic events in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Detection and analysis of proteins modified by O-linked N-acetylglucosamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Oxidation of specific methionine and tryptophan residues of apolipoprotein A-I in hepatocarcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

The preferential site of non-enzymatic glycation of human apolipoprotein A-I in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Serum glycoproteins in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Proteomic analysis of plasma from patients during an acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

O-GlcNAc signaling in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Cardioprotection by N-acetylglucosamine linkage to cellular proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008

Qualitative characteristics of HDL in young patients of an acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.03.008